← EU FEED
Health
LIVE · 3 in current feed
ARCHIVE
· 01–50 of 1391 page 01 of 28
Health Arts groups in US cities that increased culture funding during Covid have rebounded more quickly: report
Health Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T
Health Nuclear Medicine Market Valued at US$ 18.6 Billion in 2024, Set to Reach US$ 57.3 Billion by 2035 at 10.8% CAGR - Transparency Market Research
Health Fauci invokes the Fifth Amendment, declines to testify in GOP-led Senate panel's COVID-19 hearing
Health Dihydroorotate Dehydrogenase (DHODH) Inhibitors Market Expected to Witness Significant Growth Through 2036, Driven by Expanding Therapeutic Applications Across Autoimmune Diseases, Oncology, and Viral Infections | DelveInsight
Health HPV-Associated Cancer p53 Restoration Market to Reach USD 2.7 Billion by 2036, Advancing at 8.3% CAGR as Precision Oncology and p53 Reactivation Research Accelerate Clinical Development
Health Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight
Health Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687
Health Ali Fazal credits Shah Rukh Khan and Tom Cruise for reviving theatrical business after pandemic; says, “You felt like the gates opened back to the theatres”
Health Healthcare Information System Market to Exceed USD 1,538.6 Billion by 2035 as Digital Healthcare Transformation Accelerates Worldwide
Health Positron Emission Tomography (PET) Scanners Market to Surpass USD 3.1 Billion by 2035 as Advanced Diagnostic Imaging Gains Momentum
Health Why some dreams feel so real while others make no sense: New study reveals how personality, sleep and COVID-19 shape your dreams
Health Recognizing Professional Coaching: Why You Need More Than Just a Title When Booking a Session
Health Hepatocellular Carcinoma Pipeline 2026: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight
Health Glioblastoma Pipeline 2026: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight
Health Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer Market to Reach USD 3.37 Billion by 2036 at 4.5% CAGR Across the 7MM | DelveInsight
Health B-Cell Lymphoma Pipeline Accelerates as 295+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
